Literature DB >> 26889506

Reasons for delays in diagnosis of anal cancer and the effect on patient satisfaction.

Sharon Chiu, Kurian Joseph, Sunita Ghosh, Rose-Marie Cornand, Dan Schiller.   

Abstract

OBJECTIVE: To quantify the time to diagnosis of anal cancer after onset of symptoms, to identify reasons for delays in diagnosis, and to identify the effect of delays on patient satisfaction.
DESIGN: Retrospective questionnaire.
SETTING: Cross Cancer Institute in Edmonton, Alta. PARTICIPANTS: Patients newly diagnosed with anal cancer on their first visit to the centre. MAIN OUTCOME MEASURES: Timeline from first symptoms to first access to medical care and to diagnosis, and patient satisfaction.
RESULTS: Twenty-six patients completed the survey. Although most sought medical attention promptly, 19% waited for more than 6 months. At first visits after symptom onset, a rectal examination was performed in only 54% of patients, a diagnosis of hemorrhoids was given in 27% of patients, and further investigations were ordered in only 54% of patients. If a misdiagnosis of hemorrhoids was made, substantially more visits were required to diagnose the cancer. An average of 3.2 months after the first visit to a physician and 7.4 months after onset of symptoms was needed to obtain a diagnosis. Overall, 28% of patients believed there were no diagnostic delays and 40% of patients thought they were responsible for the delay. Overall, 72% of patients were satisfied with the care they received. Patients who were dissatisfied perceived the delay in diagnosis to be because no action was taken by a physician or the wait was too long for tests or referrals.
CONCLUSION: To reduce delays in diagnosis, it might be important to educate relevant populations about symptoms of anal cancer. In addition, primary care physicians must maintain a high index of suspicion of anal cancer in high-risk populations. Finally, there must be a system-wide increase in access to further investigations through gastroenterologists and general surgeons.

Entities:  

Mesh:

Year:  2015        PMID: 26889506      PMCID: PMC4642922     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  16 in total

1.  Comparison of time trends in colon, rectum and anus cancer incidence (1973-2002) in Asia, from 'Cancer Incidence in Five Continents, Vols IV-IX'.

Authors:  Hiroko Yako-Suketomo; Tomomi Marugame
Journal:  Jpn J Clin Oncol       Date:  2009-03       Impact factor: 3.019

Review 2.  Anogenital malignancies and premalignancies: facts and controversies.

Authors:  Zekayi Kutlubay; Burhan Engin; Tuba Zara; Yalçın Tüzün
Journal:  Clin Dermatol       Date:  2013 Jul-Aug       Impact factor: 3.541

3.  Time trends in colon, rectum and anus cancer mortality between 1955 and 2008 in Japan, USA and Europe based on the WHO mortality database.

Authors:  Kumiko Saika; Ryoko Machii
Journal:  Jpn J Clin Oncol       Date:  2011-09       Impact factor: 3.019

4.  Medical negligence in coloproctology.

Authors: 
Journal:  Colorectal Dis       Date:  1999-03       Impact factor: 3.788

Review 5.  Anal squamous cell carcinoma: an evolution in disease and management.

Authors:  Marc C Osborne; Justin Maykel; Eric K Johnson; Scott R Steele
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

6.  Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98-11).

Authors:  Jaffer A Ajani; Kathryn A Winter; Leonard L Gunderson; John Pedersen; Al B Benson; Charles R Thomas; Robert J Mayer; Michael G Haddock; Tyvin A Rich; Christopher G Willett
Journal:  Cancer       Date:  2010-09-01       Impact factor: 6.860

7.  Annual cost of hospitalization, inpatient rehabilitation and sick leave of anal cancer in Germany.

Authors:  Wolf Heitland; Peter K Schädlich; Xiaoyu Chen; Vanessa Rémy; Lionel Moro
Journal:  J Med Econ       Date:  2013-01-02       Impact factor: 2.448

8.  Does an erroneous diagnosis of squamous-cell carcinoma of the anal canal and anal margin at first physician visit influence prognosis?

Authors:  S L Jensen; K Hagen; M H Shokouh-Amiri; O V Nielsen
Journal:  Dis Colon Rectum       Date:  1987-05       Impact factor: 4.585

9.  Size of anal squamous cell carcinomas at diagnosis: a retrospective case series.

Authors:  T R H Read; K L Huson; J L Millar; A Haydon; I W T Porter; A E Grulich; J S Hocking; M Y Chen; C S Bradshaw; C K Fairley
Journal:  Int J STD AIDS       Date:  2013-07-15       Impact factor: 1.359

10.  Anal cancer: the case for earlier diagnosis.

Authors:  A T Edwards; L C Morus; M E Foster; G H Griffith
Journal:  J R Soc Med       Date:  1991-07       Impact factor: 18.000

View more
  9 in total

1.  Delayed Diagnosis of Anal Cancer.

Authors:  Katherine Bingmer; Asya Ofshteyn; Sharon L Stein; Emily Steinhagen
Journal:  J Gastrointest Surg       Date:  2019-08-16       Impact factor: 3.452

2.  Rectal bleeding and prolapse… not always benign diseases rather anal cancer. The importance of a correct decision making since primary care.

Authors:  G Cocorullo; R Tutino; N Falco; T Fontana; G Salamone; L Licari; G Gulotta
Journal:  G Chir       Date:  2016 May-Jun

3.  Chemoradiotherapy for fistula-related perianal squamous cell carcinoma with Crohn's disease.

Authors:  Katsuyuki Sakanaka; Kota Fujii; Hideaki Hirashima; Nobutaka Mukumoto; Hiroyuki Inoo; Ryo Narukami; Yoshiharu Sakai; Takashi Mizowaki
Journal:  Int Cancer Conf J       Date:  2021-06-30

Review 4.  Lessons learned: Preventable misses and near-misses of endoscopic procedures.

Authors:  Alla Turshudzhyan; Houman Rezaizadeh; Micheal Tadros
Journal:  World J Gastrointest Endosc       Date:  2022-05-16

5.  Diagnostic performance of magnetic resonance imaging and 3D endoanal ultrasound in detection, staging and assessment post treatment, in anal cancer.

Authors:  Alfonso Reginelli; Vincenza Granata; Roberta Fusco; Francesco Granata; Daniela Rega; Luca Roberto; Gianluca Pellino; Antonio Rotondo; Francesco Selvaggi; Francesco Izzo; Antonella Petrillo; Roberto Grassi
Journal:  Oncotarget       Date:  2017-04-04

6.  The diagnostic pathway of Parkinson's disease: a cross-sectional survey study of factors influencing patient dissatisfaction.

Authors:  Annette O A Plouvier; Tim C Olde Hartman; Olga A de Bont; Sjoerd Maandag; Bastiaan R Bloem; Chris van Weel; Antoine L M Lagro-Janssen
Journal:  BMC Fam Pract       Date:  2017-08-25       Impact factor: 2.497

7.  Factors Associated with Time Intervals for Diagnosis of Colorectal Cancer: A Hospital Based Study in Khon Kaen, Thailand.

Authors:  Attapong Rittitit; Supannee Promthet; Krittika Suwanrungruang; Kriangsak Jenwitheesuk; Chalongpon Santong; Patravoot Vatanasapt
Journal:  Asian Pac J Cancer Prev       Date:  2020-06-01

Review 8.  Radiological assessment of anal cancer: an overview and update.

Authors:  Vincenza Granata; Roberta Fusco; Alfonso Reginelli; Luca Roberto; Francesco Granata; Daniela Rega; Antonio Rotondo; Roberto Grassi; Francesco Izzo; Antonella Petrillo
Journal:  Infect Agent Cancer       Date:  2016-10-12       Impact factor: 2.965

9.  Clinical value of long noncoding RNA ZEB1 anti-sense1 in cancer patients: A meta-analysis.

Authors:  Sixiang Cheng; Shengyu Guo; Hairong He; Atipatsa Chiwanda Kaminga; Huilan Xu
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.